COVID, FDA and vaccines
Digest more
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.
President Donald Trump’s administration is slated to lay out its approach to Covid vaccination at an event Tuesday that could spell major changes in what is required to get regulatory approval for immunizations.
A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for vaccines.
FDA set to change requirements to get vaccines approved as RFK Jr continues to push skepticism about their use - New FDA framework on changes coronavirus vaccine approval will be released “in the coming days,